By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DNA sequencing developer Nabsys said today that it has reeled in $7 million in Series B venture financing in an equity round led by Stata Venture Partners.

The Providence, RI-based firm said it plans to use the financing to speed up development and commercialization of its core platform, which uses semiconductor technology in a solid-state DNA sequencing tool.

In 2009, Nabsys completed a $4 million equity round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.